Evaluation of the effect of adrenalized lidocaine with or without bicarbonate on early postoperative recovery in ambulatory hand and foot surgery with WALANT
EU CTIS ID: 2024-519650-36-00
What this study is testing
To evaluate the effect of two WALANT-type local anaesthetic protocols (with or without the addition of bicarbonate) on early postoperative recovery in ambulatory hand and foot surgery under WALANT.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patient eligible for outpatient surgery under WALANT for : Hand surgery such as carpal tunnel, stub finger, Dupuytren's disease; Foot surgery (hallux valgus or rigidus).
- Patient has given free and informed consent.
- Patient who has signed the consent form.
- Patient affiliated to or benefiting from a health insurance.
- Adult patient (≥18 years).
You likely can't join if
- Ischaemic vascular disorders such as severe Raynaud's disease, Buerger's disease and diabetic microangiopathy.
- Severe arterial hypertension.
- Obstructive cardiomyopathy.
- Hyperthyroidism
- Hypovolaemia
- Patient participating in an interventional RIPH defined in category 1
See the full eligibility criteria
- Patient eligible for outpatient surgery under WALANT for : Hand surgery such as carpal tunnel, stub finger, Dupuytren's disease; Foot surgery (hallux valgus or rigidus).
- Patient has given free and informed consent.
- Patient who has signed the consent form.
- Patient affiliated to or benefiting from a health insurance.
- Adult patient (≥18 years).
- Ischaemic vascular disorders such as severe Raynaud's disease, Buerger's disease and diabetic microangiopathy.
- Severe arterial hypertension.
- Obstructive cardiomyopathy.
- Hyperthyroidism
- Hypovolaemia
- Patient participating in an interventional RIPH defined in category 1
- Patient in an exclusion period determined by another study
- Patient under court protection, guardianship or curatorship
- Patient unable to give consent
- Patients for whom it is impossible to provide informed information
- Pregnant, parturient or breast-feeding patients
- Scleroderma.
- Known allergy to lidocaine and possibility of cross-allergy with other amide-linked local anaesthetics.
- Severe hepatic impairment
- Acute porphyria
- Intravascular anaesthesia
- Local infiltration anaesthesia in the extremities
- Coronary insufficiency
- Ventricular rhythm disorders
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.